News

Furthermore Movianto said that it would continue the existing successful cooperation in France. Alongside the storage and distribution of Daiichi Sankyo’s products, Movianto is also expected to be

The study results included demonstration that lymphocyte counts in the vascular space were reduced in a dose-related fashion. As such, Lpath achieved an objective established by Merck KGaA

Sage and Merck are expected to collaborate to create network-based computational models of disease that will contribute to Merck’s drug development strategy. Merck is expected to provide financial

The new contract, which becomes effective April 1, 2010, continues Siemens’ long-standing relationship with Premier, providing members ongoing access to Siemens’ comprehensive portfolio of diagnostic systems, tests, and

The acquisition includes Orchid’s beta-lactam antibiotic formulations manufacturing complex (comprising cephalosporin, penicillin and carbapenem facilities) and pharmaceutical research and development (R&D) facility at Irungattukottai, Chennai, as well as

Prosensa said that the objective of the open label, dose-escalating study is to evaluate the safety and tolerability of the systemic delivery of PRO044 in 12 DMD patients

COT said that in the study, animals were divided into three study groups: Group 1 (Control) animals received vehicle only (no treatment), Group 2 (Pretreatment) animals received oral

Sanofi-aventis said that the NICE appraisal committee’s preliminary recommendation is to endorse Multaq as a first choice therapeutic option after beta-blockers, which are the initial therapeutic option in

NeuroVive Pharmaceutical said that the results of the study demonstrated that NeuroSTAT is bioequivalent to Sandimmune injection and is safe and well tolerated. The NeuroSTAT cyclosporine lipid emulsion